Methods, volume 203, pages 431-446

CRISPR-Cas systems for diagnosing infectious diseases

Brezgin Sergey 1, 2
Babin Yuriy 1
Vasilyeva I N 1
Glebe Dieter 3
1
 
National Medical Research Center of Tuberculosis and Infectious Diseases, Ministry of Health, Moscow, Russia
3
 
Institute of Medical Virology, University of Giessen, Giessen, Germany
Publication typeJournal Article
Publication date2022-07-01
Journal: Methods
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor4.8
ISSN10462023, 10959130
General Biochemistry, Genetics and Molecular Biology
Molecular Biology
Abstract
Infectious diseases are a global health problem affecting billions of people. Developing rapid and sensitive diagnostic tools is key for successful patient management and curbing disease spread. Currently available diagnostics are very specific and sensitive but time-consuming and require expensive laboratory settings and well-trained personnel; thus, they are not available in resource-limited areas, for the purposes of large-scale screenings and in case of outbreaks and epidemics. Developing new, rapid, and affordable point-of-care diagnostic assays is urgently needed. This review focuses on CRISPR-based technologies and their perspectives to become platforms for point-of-care nucleic acid detection methods and as deployable diagnostic platforms that could help to identify and curb outbreaks and emerging epidemics. We describe the mechanisms and function of different classes and types of CRISPR-Cas systems, including pros and cons for developing molecular diagnostic tests and applications of each type to detect a wide range of infectious agents. Many Cas proteins (Cas3, Cas9, Cas12, Cas13, Cas14 etc.) have been leveraged to create highly accurate and sensitive diagnostic tools combined with technologies of signal amplification and fluorescent, potentiometric, colorimetric, lateral flow assay detection and other. In particular, the most advanced platforms -- SHERLOCK/v2, DETECTR, CARMEN or CRISPR-Chip -- enable detection of attomolar amounts of pathogenic nucleic acids with specificity comparable to that of PCR but with minimal technical settings. Further developing CRISPR-based diagnostic tools promises to dramatically transform molecular diagnostics, making them easily affordable and accessible virtually anywhere in the world. The burden of socially significant diseases, frequent outbreaks, recent epidemics (MERS, SARS and the ongoing COVID-19) and outbreaks of zoonotic viruses (African Swine Fever Virus etc.) urgently need the developing and distribution of express-diagnostic tools. Recently devised CRISPR-technologies represent the unprecedented opportunity to reshape epidemiological surveillance and molecular diagnostics.

Citations by journals

1
2
3
4
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 4, 8%
International Journal of Molecular Sciences
4 publications, 8%
Biosensors
Biosensors, 4, 8%
Biosensors
4 publications, 8%
Analytical Chemistry
Analytical Chemistry, 3, 6%
Analytical Chemistry
3 publications, 6%
Frontiers in Microbiology
Frontiers in Microbiology, 2, 4%
Frontiers in Microbiology
2 publications, 4%
Microbiology spectrum
Microbiology spectrum, 2, 4%
Microbiology spectrum
2 publications, 4%
Diagnostics
Diagnostics, 2, 4%
Diagnostics
2 publications, 4%
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology, 2, 4%
Frontiers in Cellular and Infection Microbiology
2 publications, 4%
Biosensors and Bioelectronics
Biosensors and Bioelectronics, 2, 4%
Biosensors and Bioelectronics
2 publications, 4%
The Analyst
The Analyst, 2, 4%
The Analyst
2 publications, 4%
Talanta
Talanta, 2, 4%
Talanta
2 publications, 4%
Bioengineering
Bioengineering, 1, 2%
Bioengineering
1 publication, 2%
Genes
Genes, 1, 2%
Genes
1 publication, 2%
Pathogens
Pathogens, 1, 2%
Pathogens
1 publication, 2%
Talanta Open
Talanta Open, 1, 2%
Talanta Open
1 publication, 2%
Agronomy
Agronomy, 1, 2%
Agronomy
1 publication, 2%
Biomicrofluidics
Biomicrofluidics, 1, 2%
Biomicrofluidics
1 publication, 2%
Molecular Ecology Resources
Molecular Ecology Resources, 1, 2%
Molecular Ecology Resources
1 publication, 2%
EPMA Journal
EPMA Journal, 1, 2%
EPMA Journal
1 publication, 2%
Applied Science and Convergence Technology, 1, 2%
Applied Science and Convergence Technology
1 publication, 2%
Molecular Medicine Reports
Molecular Medicine Reports, 1, 2%
Molecular Medicine Reports
1 publication, 2%
Sustainable Food Technology
Sustainable Food Technology, 1, 2%
Sustainable Food Technology
1 publication, 2%
Sensors and Actuators, B: Chemical
Sensors and Actuators, B: Chemical, 1, 2%
Sensors and Actuators, B: Chemical
1 publication, 2%
ACS Omega
ACS Omega, 1, 2%
ACS Omega
1 publication, 2%
Infection
Infection, 1, 2%
Infection
1 publication, 2%
Analytical Methods
Analytical Methods, 1, 2%
Analytical Methods
1 publication, 2%
PLoS ONE
PLoS ONE, 1, 2%
PLoS ONE
1 publication, 2%
Clinical Chemistry and Laboratory Medicine
Clinical Chemistry and Laboratory Medicine, 1, 2%
Clinical Chemistry and Laboratory Medicine
1 publication, 2%
Journal of Medical Virology
Journal of Medical Virology, 1, 2%
Journal of Medical Virology
1 publication, 2%
AIDS Research and Human Retroviruses
AIDS Research and Human Retroviruses, 1, 2%
AIDS Research and Human Retroviruses
1 publication, 2%
1
2
3
4

Citations by publishers

2
4
6
8
10
12
14
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 14, 28%
Multidisciplinary Digital Publishing Institute (MDPI)
14 publications, 28%
Elsevier
Elsevier, 9, 18%
Elsevier
9 publications, 18%
Frontiers Media S.A.
Frontiers Media S.A., 4, 8%
Frontiers Media S.A.
4 publications, 8%
American Chemical Society (ACS)
American Chemical Society (ACS), 4, 8%
American Chemical Society (ACS)
4 publications, 8%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 4, 8%
Royal Society of Chemistry (RSC)
4 publications, 8%
American Society for Microbiology
American Society for Microbiology, 2, 4%
American Society for Microbiology
2 publications, 4%
Wiley
Wiley, 2, 4%
Wiley
2 publications, 4%
Springer Nature
Springer Nature, 2, 4%
Springer Nature
2 publications, 4%
American Institute of Physics (AIP)
American Institute of Physics (AIP), 1, 2%
American Institute of Physics (AIP)
1 publication, 2%
The Korean Vacuum Society, 1, 2%
The Korean Vacuum Society
1 publication, 2%
Spandidos Publications
Spandidos Publications, 1, 2%
Spandidos Publications
1 publication, 2%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 2%
Public Library of Science (PLoS)
1 publication, 2%
Walter de Gruyter
Walter de Gruyter, 1, 2%
Walter de Gruyter
1 publication, 2%
Mary Ann Liebert
Mary Ann Liebert, 1, 2%
Mary Ann Liebert
1 publication, 2%
Pleiades Publishing
Pleiades Publishing, 1, 2%
Pleiades Publishing
1 publication, 2%
2
4
6
8
10
12
14
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Kostyusheva A. et al. CRISPR-Cas systems for diagnosing infectious diseases // Methods. 2022. Vol. 203. pp. 431-446.
GOST all authors (up to 50) Copy
Kostyusheva A., Brezgin S., Babin Y., Vasilyeva I. N., Glebe D., Kostyushev D., Chulanov V. CRISPR-Cas systems for diagnosing infectious diseases // Methods. 2022. Vol. 203. pp. 431-446.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.ymeth.2021.04.007
UR - https://doi.org/10.1016%2Fj.ymeth.2021.04.007
TI - CRISPR-Cas systems for diagnosing infectious diseases
T2 - Methods
AU - Kostyusheva, Anastasiya
AU - Brezgin, Sergey
AU - Babin, Yuriy
AU - Vasilyeva, I N
AU - Glebe, Dieter
AU - Kostyushev, Dmitry
AU - Chulanov, Vladimir
PY - 2022
DA - 2022/07/01 00:00:00
PB - Elsevier
SP - 431-446
VL - 203
PMID - 33839288
SN - 1046-2023
SN - 1095-9130
ER -
BibTex
Cite this
BibTex Copy
@article{2022_Kostyusheva,
author = {Anastasiya Kostyusheva and Sergey Brezgin and Yuriy Babin and I N Vasilyeva and Dieter Glebe and Dmitry Kostyushev and Vladimir Chulanov},
title = {CRISPR-Cas systems for diagnosing infectious diseases},
journal = {Methods},
year = {2022},
volume = {203},
publisher = {Elsevier},
month = {jul},
url = {https://doi.org/10.1016%2Fj.ymeth.2021.04.007},
pages = {431--446},
doi = {10.1016/j.ymeth.2021.04.007}
}
Found error?